The global antimicrobial peptides market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The market is driven by the increasing demand for antimicrobial peptides in pharmaceuticals and feed additives applications. The pharmaceuticals application segment accounted for more than 86% of the total revenue in 2018, owing to its wide range of applications such as treatment of bacterial infections, cancer therapy, and prevention of biofilm formation.
The animal antimicrobial peptides segment held a comparatively larger share in global market which accounted for about 60% in 2018 due to their wide range of applications such as treatment against bacterial infections and prevention against biofilm formation. The animal antimicrobial peptides are also used as feed additives which helps improve livestock health and productivity by reducing the risk from pathogens that cause diseases like mastitis or foot-and-mouth disease (FMD).
Antimicrobial peptides are a group of molecules that are found in the human body and have been shown to be effective against bacteria, fungi, and viruses. Antimicrobial peptides can be found in many different types of organisms including humans, plants, insects, and animals. The antimicrobial peptide market is expected to grow at a CAGR of 8.5% from 2017-2023.
Industry Growth Insights published a new data on “Antimicrobial Peptides Market”. The research report is titled “Antimicrobial Peptides Market research by Types (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.), By Applications (Pharmaceuticals, Feed Additives, Others, Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.), By Players/Companies AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antimicrobial Peptides Market Research Report
By Type
Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
By Application
Pharmaceuticals, Feed Additives, Others, Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
By Companies
AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Antimicrobial Peptides Market Report Segments:
The global Antimicrobial Peptides market is segmented on the basis of:
Types
Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals, Feed Additives, Others, Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AnaSpec
- AMP Biotech
- Phoenix Biotech
- Novabiotics
- Chinese Peptide
- Ontores
- GenScript
- Hycult Biotech
- Sunsmile
- Ruixing Biotechnology
- Zhongnong Yingtai Biotechnology
- Glam Technology
Highlights of The Antimicrobial Peptides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plant Antimicrobial Peptides
- Bacterial Antimicrobial Peptides
- Animal Antimicrobial Peptides
- Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
- By Application:
- Pharmaceuticals
- Feed Additives
- Others
- Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antimicrobial Peptides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antimicrobial peptides are a type of protein that helps to fight against bacteria and other microorganisms. They are often found in natural products, such as herbs and spices, and can be used to treat infections.
Some of the major players in the antimicrobial peptides market are AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology.
The antimicrobial peptides market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antimicrobial Peptides Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Antimicrobial Peptides Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Antimicrobial Peptides Market - Supply Chain
4.5. Global Antimicrobial Peptides Market Forecast
4.5.1. Antimicrobial Peptides Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Antimicrobial Peptides Market Size (000 Units) and Y-o-Y Growth
4.5.3. Antimicrobial Peptides Market Absolute $ Opportunity
5. Global Antimicrobial Peptides Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Antimicrobial Peptides Market Size and Volume Forecast by Type
5.3.1. Plant Antimicrobial Peptides
5.3.2. Bacterial Antimicrobial Peptides
5.3.3. Animal Antimicrobial Peptides
5.3.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Antimicrobial Peptides Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Antimicrobial Peptides Market Size and Volume Forecast by Application
6.3.1. Pharmaceuticals
6.3.2. Feed Additives
6.3.3. Others
6.3.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Antimicrobial Peptides Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Antimicrobial Peptides Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Antimicrobial Peptides Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Antimicrobial Peptides Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Antimicrobial Peptides Demand Share Forecast, 2019-2026
9. North America Antimicrobial Peptides Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Antimicrobial Peptides Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Antimicrobial Peptides Market Size and Volume Forecast by Application
9.4.1. Pharmaceuticals
9.4.2. Feed Additives
9.4.3. Others
9.4.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Antimicrobial Peptides Market Size and Volume Forecast by Type
9.7.1. Plant Antimicrobial Peptides
9.7.2. Bacterial Antimicrobial Peptides
9.7.3. Animal Antimicrobial Peptides
9.7.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Antimicrobial Peptides Demand Share Forecast, 2019-2026
10. Latin America Antimicrobial Peptides Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Antimicrobial Peptides Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Antimicrobial Peptides Market Size and Volume Forecast by Application
10.4.1. Pharmaceuticals
10.4.2. Feed Additives
10.4.3. Others
10.4.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Antimicrobial Peptides Market Size and Volume Forecast by Type
10.7.1. Plant Antimicrobial Peptides
10.7.2. Bacterial Antimicrobial Peptides
10.7.3. Animal Antimicrobial Peptides
10.7.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Antimicrobial Peptides Demand Share Forecast, 2019-2026
11. Europe Antimicrobial Peptides Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Antimicrobial Peptides Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Antimicrobial Peptides Market Size and Volume Forecast by Application
11.4.1. Pharmaceuticals
11.4.2. Feed Additives
11.4.3. Others
11.4.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Antimicrobial Peptides Market Size and Volume Forecast by Type
11.7.1. Plant Antimicrobial Peptides
11.7.2. Bacterial Antimicrobial Peptides
11.7.3. Animal Antimicrobial Peptides
11.7.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Antimicrobial Peptides Demand Share, 2019-2026
12. Asia Pacific Antimicrobial Peptides Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Antimicrobial Peptides Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Antimicrobial Peptides Market Size and Volume Forecast by Application
12.4.1. Pharmaceuticals
12.4.2. Feed Additives
12.4.3. Others
12.4.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Antimicrobial Peptides Market Size and Volume Forecast by Type
12.7.1. Plant Antimicrobial Peptides
12.7.2. Bacterial Antimicrobial Peptides
12.7.3. Animal Antimicrobial Peptides
12.7.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Antimicrobial Peptides Demand Share, 2019-2026
13. Middle East & Africa Antimicrobial Peptides Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Antimicrobial Peptides Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Antimicrobial Peptides Market Size and Volume Forecast by Application
13.4.1. Pharmaceuticals
13.4.2. Feed Additives
13.4.3. Others
13.4.4. Pharmaceuticals is the most common application of antimicrobial peptides, which took up more than 86% of the clients in 2018.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Antimicrobial Peptides Market Size and Volume Forecast by Type
13.7.1. Plant Antimicrobial Peptides
13.7.2. Bacterial Antimicrobial Peptides
13.7.3. Animal Antimicrobial Peptides
13.7.4. Animal antimicrobial peptides hold a comparatively larger share in global market, which accounts for about 60% in 2018.
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Antimicrobial Peptides Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Antimicrobial Peptides Market: Market Share Analysis
14.2. Antimicrobial Peptides Distributors and Customers
14.3. Antimicrobial Peptides Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AnaSpec
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AMP Biotech
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Phoenix Biotech
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novabiotics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Chinese Peptide
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ontores
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GenScript
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hycult Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sunsmile
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Ruixing Biotechnology
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zhongnong Yingtai Biotechnology
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Glam Technology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
